Roche Holding | ROG - Spese Operative





Spese Operative Cambiamento Data
AbbVie USD 10.27B 1000K 2026-06
Alcon AG USD 2.41B 4M 2026-03
Almirall EUR 531.16M 13.76M 2026-06
Amgen USD 4.78B 1.12B 2026-03
AstraZeneca USD 12.22B 4.04B 2026-06
Bayer EUR 9.88B 452M 2026-03
Biogen USD 2.98B 1.02B 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Eli Lilly USD 10.02B 285M 2026-03
Fresenius EUR 5.25B 337M 2025-12
Fresenius Medical Care EUR 4.34B 63M 2026-03
Genmab DKK 798M 235M 2025-12
Gilead Sciences USD 23.52B 18.55B 2026-03
GlaxoSmithKline GBP 5.8B 468M 2026-06
GRIFOLS EUR 1.55B 94M 2026-06
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Lakefront Biotherapeutics EUR 70.18M 50.08M 2026-03
Lonza CHF 2.9B 184M 2025-06
Merck EUR 4.09B 687M 2026-03
Merck USD 18.17B 8.01B 2026-03
Novartis USD 10.2B 912M 2026-06
Orion EUR 345M 42.1M 2026-06
Pfizer USD 90.1B 77.19B 2026-03
Philips EUR 3.75B 147M 2026-06
Recordati EUR 493.59M 11.28M 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 9.92B 607M 2026-06
UCB EUR 2.96B 196M 2025-12